Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.01946472 |
2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.00530793 |
3 | vocalization behavior (GO:0071625) | 5.74202899 |
4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.60415739 |
5 | synaptic vesicle exocytosis (GO:0016079) | 5.55843595 |
6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.37556002 |
7 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.26282561 |
8 | protein localization to synapse (GO:0035418) | 5.21078840 |
9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.20369368 |
10 | glutamate secretion (GO:0014047) | 5.19832497 |
11 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.16745404 |
12 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.08347682 |
13 | locomotory exploration behavior (GO:0035641) | 5.03846566 |
14 | synaptic vesicle maturation (GO:0016188) | 4.99353037 |
15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.89520332 |
16 | synaptic transmission, glutamatergic (GO:0035249) | 4.85351800 |
17 | neuron cell-cell adhesion (GO:0007158) | 4.84731680 |
18 | glutamate receptor signaling pathway (GO:0007215) | 4.81326838 |
19 | L-amino acid import (GO:0043092) | 4.77624773 |
20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.66520187 |
21 | neuronal action potential propagation (GO:0019227) | 4.59312280 |
22 | * neuron-neuron synaptic transmission (GO:0007270) | 4.59303062 |
23 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.41164474 |
24 | regulation of synaptic vesicle transport (GO:1902803) | 4.40964993 |
25 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.38945504 |
26 | neurotransmitter secretion (GO:0007269) | 4.32498662 |
27 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.26632308 |
28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.26107666 |
29 | presynaptic membrane assembly (GO:0097105) | 4.16055276 |
30 | positive regulation of synapse maturation (GO:0090129) | 4.15886475 |
31 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.11197129 |
32 | long-term synaptic potentiation (GO:0060291) | 4.10385209 |
33 | positive regulation of dendritic spine development (GO:0060999) | 4.09961488 |
34 | long-term memory (GO:0007616) | 4.09667993 |
35 | positive regulation of membrane potential (GO:0045838) | 4.07836503 |
36 | exploration behavior (GO:0035640) | 4.05305589 |
37 | regulation of postsynaptic membrane potential (GO:0060078) | 4.03892803 |
38 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.03490864 |
39 | amino acid import (GO:0043090) | 4.02518029 |
40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.02165981 |
41 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.98387037 |
42 | regulation of synapse structural plasticity (GO:0051823) | 3.94543404 |
43 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.93116606 |
44 | regulation of synaptic plasticity (GO:0048167) | 3.91318784 |
45 | sodium ion export (GO:0071436) | 3.88554685 |
46 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.85071798 |
47 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.83162483 |
48 | presynaptic membrane organization (GO:0097090) | 3.82355451 |
49 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.82261044 |
50 | gamma-aminobutyric acid transport (GO:0015812) | 3.81499174 |
51 | postsynaptic membrane organization (GO:0001941) | 3.80773635 |
52 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.76548235 |
53 | behavioral defense response (GO:0002209) | 3.74608529 |
54 | behavioral fear response (GO:0001662) | 3.74608529 |
55 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.71325284 |
56 | behavioral response to cocaine (GO:0048148) | 3.63266704 |
57 | neuron recognition (GO:0008038) | 3.63122331 |
58 | positive regulation of neurotransmitter transport (GO:0051590) | 3.62784868 |
59 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.61955886 |
60 | response to histamine (GO:0034776) | 3.60562060 |
61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.60454652 |
62 | neuronal ion channel clustering (GO:0045161) | 3.57162412 |
63 | striatum development (GO:0021756) | 3.55043099 |
64 | transmission of nerve impulse (GO:0019226) | 3.53005555 |
65 | regulation of neurotransmitter secretion (GO:0046928) | 3.51764198 |
66 | neuromuscular synaptic transmission (GO:0007274) | 3.50191654 |
67 | dendritic spine morphogenesis (GO:0060997) | 3.49131742 |
68 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.48308706 |
69 | regulation of glutamate secretion (GO:0014048) | 3.48000025 |
70 | primary amino compound metabolic process (GO:1901160) | 3.47767389 |
71 | synaptic vesicle endocytosis (GO:0048488) | 3.47525930 |
72 | fear response (GO:0042596) | 3.47208789 |
73 | axon ensheathment in central nervous system (GO:0032291) | 3.45431468 |
74 | central nervous system myelination (GO:0022010) | 3.45431468 |
75 | neurotransmitter transport (GO:0006836) | 3.43523631 |
76 | membrane depolarization (GO:0051899) | 3.39848213 |
77 | regulation of synapse maturation (GO:0090128) | 3.39277742 |
78 | learning (GO:0007612) | 3.34986520 |
79 | startle response (GO:0001964) | 3.33501667 |
80 | regulation of neurotransmitter transport (GO:0051588) | 3.32932412 |
81 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.32127968 |
82 | positive regulation of synaptic transmission (GO:0050806) | 3.30170538 |
83 | membrane depolarization during action potential (GO:0086010) | 3.29013215 |
84 | phosphorelay signal transduction system (GO:0000160) | 3.27203852 |
85 | regulation of dendritic spine development (GO:0060998) | 3.25780482 |
86 | neuronal action potential (GO:0019228) | 3.24326025 |
87 | proline transport (GO:0015824) | 3.24243171 |
88 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.23815408 |
89 | axonal fasciculation (GO:0007413) | 3.22606377 |
90 | membrane hyperpolarization (GO:0060081) | 3.22466671 |
91 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.22304729 |
92 | long term synaptic depression (GO:0060292) | 3.22265025 |
93 | regulation of neurotransmitter levels (GO:0001505) | 3.20904860 |
94 | layer formation in cerebral cortex (GO:0021819) | 3.20248748 |
95 | regulation of vesicle fusion (GO:0031338) | 3.19114480 |
96 | adult walking behavior (GO:0007628) | 3.18600396 |
97 | negative regulation of amino acid transport (GO:0051956) | 3.18561968 |
98 | regulation of synaptic transmission (GO:0050804) | 3.18535866 |
99 | * synaptic transmission (GO:0007268) | 3.18371096 |
100 | calcium ion-dependent exocytosis (GO:0017156) | 3.18102951 |
101 | regulation of female receptivity (GO:0045924) | 3.16022392 |
102 | cerebellar granule cell differentiation (GO:0021707) | 3.15390419 |
103 | potassium ion import (GO:0010107) | 3.14881513 |
104 | acidic amino acid transport (GO:0015800) | 3.12074180 |
105 | cellular potassium ion homeostasis (GO:0030007) | 3.11227965 |
106 | auditory behavior (GO:0031223) | 3.10737005 |
107 | cell communication by electrical coupling (GO:0010644) | 3.10611538 |
108 | response to auditory stimulus (GO:0010996) | 3.10122552 |
109 | prepulse inhibition (GO:0060134) | 3.09672088 |
110 | detection of calcium ion (GO:0005513) | 3.09404334 |
111 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.07744146 |
112 | neurotransmitter uptake (GO:0001504) | 3.06573080 |
113 | intraspecies interaction between organisms (GO:0051703) | 3.06557312 |
114 | social behavior (GO:0035176) | 3.06557312 |
115 | potassium ion homeostasis (GO:0055075) | 3.05895348 |
116 | neuromuscular process controlling posture (GO:0050884) | 3.04869625 |
117 | neuromuscular process controlling balance (GO:0050885) | 3.02527376 |
118 | mechanosensory behavior (GO:0007638) | 3.02411455 |
119 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.02039406 |
120 | activation of protein kinase A activity (GO:0034199) | 3.00409245 |
121 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.99294928 |
122 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.99077175 |
123 | synaptic transmission, dopaminergic (GO:0001963) | 2.98788340 |
124 | female mating behavior (GO:0060180) | 2.98578696 |
125 | negative regulation of dendrite development (GO:2000171) | 2.98375869 |
126 | synapse assembly (GO:0007416) | 2.96920324 |
127 | serotonin metabolic process (GO:0042428) | 2.96174157 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.31956817 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.50902754 |
3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14981630 |
4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02954514 |
5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.97287639 |
6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.66707575 |
7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.63895483 |
8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62882035 |
9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.57876312 |
10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.57876312 |
11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54864879 |
12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46470972 |
13 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46228836 |
14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.44733678 |
15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39976296 |
16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38464787 |
17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37352081 |
18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.28800130 |
19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.23160462 |
20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.14982412 |
21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.14705314 |
22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.09770876 |
23 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08354600 |
24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08195764 |
25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08007368 |
26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.97570252 |
27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.97188236 |
28 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.95852024 |
29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89776848 |
30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.87201335 |
31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86449187 |
32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85023076 |
33 | * ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82214802 |
34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.79668499 |
35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.75739369 |
36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75051212 |
37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63836264 |
38 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.63428716 |
39 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48506223 |
40 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44587962 |
41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42352508 |
42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40922738 |
43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38592436 |
44 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38483665 |
45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36988577 |
46 | STAT3_23295773_ChIP-Seq_U87_Human | 1.36936676 |
47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36922205 |
48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.36735836 |
49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.36561199 |
50 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36231034 |
51 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35242928 |
52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31444371 |
53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28791066 |
54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.28675721 |
55 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28050388 |
56 | * TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25578511 |
57 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25345957 |
58 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24625990 |
59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23877531 |
60 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.23339036 |
61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20862338 |
62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19945883 |
63 | AR_19668381_ChIP-Seq_PC3_Human | 1.19893652 |
64 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18438491 |
65 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.18016769 |
66 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.15624535 |
67 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14515438 |
68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14365516 |
69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13918558 |
70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13731352 |
71 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13396641 |
72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12712580 |
73 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12600504 |
74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12332486 |
75 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12319497 |
76 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11410430 |
77 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.11301472 |
78 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10894866 |
79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10667018 |
80 | JUN_21703547_ChIP-Seq_K562_Human | 1.06712756 |
81 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06667408 |
82 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05972430 |
83 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02725367 |
84 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02552488 |
85 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02198305 |
86 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02120309 |
87 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01476360 |
88 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00596363 |
89 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00239312 |
90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00239312 |
91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99632177 |
92 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99632177 |
93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99582317 |
94 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99579428 |
95 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99206494 |
96 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97964747 |
97 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97579103 |
98 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97438590 |
99 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96918106 |
100 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96120523 |
101 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95862496 |
102 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95834643 |
103 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93338403 |
104 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91635284 |
105 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89995140 |
106 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89861899 |
107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89843261 |
108 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89448822 |
109 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.89421112 |
110 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89052880 |
111 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88640131 |
112 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.88176908 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.74696254 |
2 | MP0003880_abnormal_central_pattern | 5.48235212 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.26517008 |
4 | MP0009745_abnormal_behavioral_response | 3.74376315 |
5 | MP0002822_catalepsy | 3.70484443 |
6 | MP0002063_abnormal_learning/memory/cond | 3.55809798 |
7 | MP0004270_analgesia | 3.48921650 |
8 | MP0002064_seizures | 3.37234688 |
9 | MP0009046_muscle_twitch | 3.26246142 |
10 | MP0001968_abnormal_touch/_nociception | 3.13777833 |
11 | MP0002572_abnormal_emotion/affect_behav | 3.04447597 |
12 | MP0002272_abnormal_nervous_system | 2.74562509 |
13 | MP0001486_abnormal_startle_reflex | 2.65955260 |
14 | MP0002736_abnormal_nociception_after | 2.57710531 |
15 | MP0001501_abnormal_sleep_pattern | 2.48299365 |
16 | MP0002734_abnormal_mechanical_nocicepti | 2.38777755 |
17 | MP0002735_abnormal_chemical_nociception | 2.33108900 |
18 | MP0005423_abnormal_somatic_nervous | 2.21027598 |
19 | MP0001440_abnormal_grooming_behavior | 2.11370590 |
20 | MP0003787_abnormal_imprinting | 2.04553971 |
21 | MP0005646_abnormal_pituitary_gland | 2.03278111 |
22 | MP0003879_abnormal_hair_cell | 2.01385518 |
23 | MP0002067_abnormal_sensory_capabilities | 2.00232626 |
24 | MP0009780_abnormal_chondrocyte_physiolo | 1.99181772 |
25 | MP0001970_abnormal_pain_threshold | 1.81518565 |
26 | MP0001529_abnormal_vocalization | 1.74856946 |
27 | MP0002733_abnormal_thermal_nociception | 1.74302007 |
28 | MP0008569_lethality_at_weaning | 1.73467058 |
29 | MP0002557_abnormal_social/conspecific_i | 1.72339163 |
30 | MP0001984_abnormal_olfaction | 1.68977397 |
31 | MP0005386_behavior/neurological_phenoty | 1.66572565 |
32 | MP0004924_abnormal_behavior | 1.66572565 |
33 | MP0004811_abnormal_neuron_physiology | 1.63821596 |
34 | MP0002184_abnormal_innervation | 1.61727319 |
35 | MP0001188_hyperpigmentation | 1.59883407 |
36 | MP0000778_abnormal_nervous_system | 1.56463080 |
37 | MP0003329_amyloid_beta_deposits | 1.37202636 |
38 | MP0002066_abnormal_motor_capabilities/c | 1.36613727 |
39 | MP0000955_abnormal_spinal_cord | 1.35686357 |
40 | MP0002909_abnormal_adrenal_gland | 1.34344377 |
41 | MP0002882_abnormal_neuron_morphology | 1.32315588 |
42 | MP0004858_abnormal_nervous_system | 1.31586041 |
43 | MP0004142_abnormal_muscle_tone | 1.31232121 |
44 | MP0001905_abnormal_dopamine_level | 1.30668299 |
45 | MP0006276_abnormal_autonomic_nervous | 1.27096185 |
46 | MP0003633_abnormal_nervous_system | 1.25546223 |
47 | MP0002876_abnormal_thyroid_physiology | 1.23601046 |
48 | MP0002638_abnormal_pupillary_reflex | 1.16686768 |
49 | MP0003122_maternal_imprinting | 1.15485711 |
50 | MP0005410_abnormal_fertilization | 1.14033132 |
51 | MP0001502_abnormal_circadian_rhythm | 1.12538105 |
52 | MP0008872_abnormal_physiological_respon | 1.12451509 |
53 | MP0005645_abnormal_hypothalamus_physiol | 1.11367936 |
54 | MP0003631_nervous_system_phenotype | 1.05978277 |
55 | MP0004885_abnormal_endolymph | 1.03262126 |
56 | MP0002152_abnormal_brain_morphology | 1.00023668 |
57 | MP0008874_decreased_physiological_sensi | 0.99334156 |
58 | MP0002837_dystrophic_cardiac_calcinosis | 0.98409433 |
59 | MP0001986_abnormal_taste_sensitivity | 0.97639484 |
60 | MP0002069_abnormal_eating/drinking_beha | 0.97520080 |
61 | MP0010386_abnormal_urinary_bladder | 0.93514931 |
62 | MP0008877_abnormal_DNA_methylation | 0.92589573 |
63 | MP0004147_increased_porphyrin_level | 0.92113681 |
64 | MP0000751_myopathy | 0.91372309 |
65 | MP0005551_abnormal_eye_electrophysiolog | 0.91134896 |
66 | MP0005187_abnormal_penis_morphology | 0.89622377 |
67 | MP0004085_abnormal_heartbeat | 0.89193808 |
68 | MP0001177_atelectasis | 0.88847699 |
69 | MP0001963_abnormal_hearing_physiology | 0.87795096 |
70 | MP0004145_abnormal_muscle_electrophysio | 0.87467327 |
71 | MP0003123_paternal_imprinting | 0.86033870 |
72 | MP0005409_darkened_coat_color | 0.85836941 |
73 | MP0002229_neurodegeneration | 0.84123491 |
74 | MP0005394_taste/olfaction_phenotype | 0.79681486 |
75 | MP0005499_abnormal_olfactory_system | 0.79681486 |
76 | MP0004215_abnormal_myocardial_fiber | 0.78027827 |
77 | MP0005171_absent_coat_pigmentation | 0.77295794 |
78 | MP0004742_abnormal_vestibular_system | 0.76670876 |
79 | MP0000013_abnormal_adipose_tissue | 0.76436078 |
80 | MP0001485_abnormal_pinna_reflex | 0.76321186 |
81 | MP0003121_genomic_imprinting | 0.73553233 |
82 | MP0003698_abnormal_male_reproductive | 0.72732400 |
83 | MP0003075_altered_response_to | 0.71962654 |
84 | MP0004484_altered_response_of | 0.70682729 |
85 | MP0008961_abnormal_basal_metabolism | 0.69648209 |
86 | MP0006292_abnormal_olfactory_placode | 0.68638391 |
87 | MP0001664_abnormal_digestion | 0.68228755 |
88 | MP0005535_abnormal_body_temperature | 0.67877261 |
89 | MP0002752_abnormal_somatic_nervous | 0.67537353 |
90 | MP0003632_abnormal_nervous_system | 0.66707627 |
91 | MP0005253_abnormal_eye_physiology | 0.65638330 |
92 | MP0000631_abnormal_neuroendocrine_gland | 0.65624130 |
93 | MP0003646_muscle_fatigue | 0.65422404 |
94 | MP0004233_abnormal_muscle_weight | 0.64101854 |
95 | MP0005167_abnormal_blood-brain_barrier | 0.63970901 |
96 | MP0000569_abnormal_digit_pigmentation | 0.62592162 |
97 | MP0003861_abnormal_nervous_system | 0.59193985 |
98 | MP0006072_abnormal_retinal_apoptosis | 0.58924352 |
99 | MP0001348_abnormal_lacrimal_gland | 0.58710772 |
100 | MP0003183_abnormal_peptide_metabolism | 0.58412170 |
101 | MP0003315_abnormal_perineum_morphology | 0.57166650 |
102 | MP0002090_abnormal_vision | 0.56606118 |
103 | MP0000026_abnormal_inner_ear | 0.54064863 |
104 | MP0001346_abnormal_lacrimal_gland | 0.53842156 |
105 | MP0003634_abnormal_glial_cell | 0.53357742 |
106 | MP0003690_abnormal_glial_cell | 0.52819457 |
107 | MP0002138_abnormal_hepatobiliary_system | 0.52578964 |
108 | MP0004130_abnormal_muscle_cell | 0.52490476 |
109 | MP0003137_abnormal_impulse_conducting | 0.52105579 |
110 | MP0001943_abnormal_respiration | 0.52088948 |
111 | MP0000604_amyloidosis | 0.51943250 |
112 | MP0010769_abnormal_survival | 0.51507421 |
113 | MP0010770_preweaning_lethality | 0.51154903 |
114 | MP0002082_postnatal_lethality | 0.51154903 |
115 | MP0004043_abnormal_pH_regulation | 0.50987549 |
116 | MP0004510_myositis | 0.49645311 |
117 | MP0000920_abnormal_myelination | 0.49066695 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 9.73193573 |
2 | Myokymia (HP:0002411) | 7.04307257 |
3 | Focal seizures (HP:0007359) | 6.35130884 |
4 | Epileptic encephalopathy (HP:0200134) | 5.97550294 |
5 | Febrile seizures (HP:0002373) | 5.60945726 |
6 | Atonic seizures (HP:0010819) | 5.59542680 |
7 | Hyperventilation (HP:0002883) | 4.88618832 |
8 | Absence seizures (HP:0002121) | 4.72927477 |
9 | Visual hallucinations (HP:0002367) | 4.56717523 |
10 | Progressive cerebellar ataxia (HP:0002073) | 4.53772033 |
11 | Dialeptic seizures (HP:0011146) | 4.48895967 |
12 | Generalized tonic-clonic seizures (HP:0002069) | 4.27266260 |
13 | Broad-based gait (HP:0002136) | 4.05142021 |
14 | Gaze-evoked nystagmus (HP:0000640) | 3.92058761 |
15 | Poor eye contact (HP:0000817) | 3.57523639 |
16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.41507556 |
17 | Dysdiadochokinesis (HP:0002075) | 3.36232113 |
18 | Amblyopia (HP:0000646) | 3.34055958 |
19 | Action tremor (HP:0002345) | 3.21224424 |
20 | Impaired social interactions (HP:0000735) | 3.19159926 |
21 | Abnormal social behavior (HP:0012433) | 3.19159926 |
22 | Cerebral hypomyelination (HP:0006808) | 3.08741836 |
23 | Abnormal eating behavior (HP:0100738) | 3.08134829 |
24 | Dysmetria (HP:0001310) | 3.05582845 |
25 | Epileptiform EEG discharges (HP:0011182) | 3.02981375 |
26 | Truncal ataxia (HP:0002078) | 2.94055159 |
27 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.93272125 |
28 | Anxiety (HP:0000739) | 2.87449208 |
29 | Excessive salivation (HP:0003781) | 2.84762664 |
30 | Drooling (HP:0002307) | 2.84762664 |
31 | Depression (HP:0000716) | 2.83380033 |
32 | Genetic anticipation (HP:0003743) | 2.81273089 |
33 | Papilledema (HP:0001085) | 2.79092996 |
34 | Impaired smooth pursuit (HP:0007772) | 2.76392126 |
35 | Scanning speech (HP:0002168) | 2.74047399 |
36 | Dysmetric saccades (HP:0000641) | 2.71086764 |
37 | EEG with generalized epileptiform discharges (HP:0011198) | 2.70077957 |
38 | Absent speech (HP:0001344) | 2.66090150 |
39 | Stereotypic behavior (HP:0000733) | 2.65591772 |
40 | Postural instability (HP:0002172) | 2.59210969 |
41 | Aplasia involving bones of the extremities (HP:0009825) | 2.58067894 |
42 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.58067894 |
43 | Aplasia of the phalanges of the hand (HP:0009802) | 2.58067894 |
44 | Ankle clonus (HP:0011448) | 2.57327377 |
45 | Protruding tongue (HP:0010808) | 2.56511395 |
46 | Abnormality of the lower motor neuron (HP:0002366) | 2.54108437 |
47 | Inability to walk (HP:0002540) | 2.50347981 |
48 | Torticollis (HP:0000473) | 2.47403863 |
49 | Akinesia (HP:0002304) | 2.46948178 |
50 | Hypsarrhythmia (HP:0002521) | 2.46127490 |
51 | Focal dystonia (HP:0004373) | 2.44648637 |
52 | Progressive inability to walk (HP:0002505) | 2.43813854 |
53 | Clonus (HP:0002169) | 2.42753291 |
54 | Impaired vibratory sensation (HP:0002495) | 2.41125827 |
55 | Abnormality of binocular vision (HP:0011514) | 2.39176561 |
56 | Diplopia (HP:0000651) | 2.39176561 |
57 | Polyphagia (HP:0002591) | 2.38729224 |
58 | Status epilepticus (HP:0002133) | 2.36874346 |
59 | Neurofibrillary tangles (HP:0002185) | 2.36349664 |
60 | Bradykinesia (HP:0002067) | 2.34863510 |
61 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.30967134 |
62 | Fetal akinesia sequence (HP:0001989) | 2.28020995 |
63 | Supranuclear gaze palsy (HP:0000605) | 2.27734277 |
64 | Annular pancreas (HP:0001734) | 2.26244663 |
65 | Urinary urgency (HP:0000012) | 2.24637168 |
66 | Delayed CNS myelination (HP:0002188) | 2.24019442 |
67 | Hemiparesis (HP:0001269) | 2.22472558 |
68 | Spastic gait (HP:0002064) | 2.21682076 |
69 | Blue irides (HP:0000635) | 2.20841205 |
70 | Abnormal hair whorl (HP:0010721) | 2.18050987 |
71 | Gait imbalance (HP:0002141) | 2.17588201 |
72 | Generalized myoclonic seizures (HP:0002123) | 2.15126154 |
73 | Incomplete penetrance (HP:0003829) | 2.14303578 |
74 | Craniofacial dystonia (HP:0012179) | 2.10924321 |
75 | Hemiplegia (HP:0002301) | 2.09127155 |
76 | Mutism (HP:0002300) | 2.08629357 |
77 | Termporal pattern (HP:0011008) | 2.08596281 |
78 | Insidious onset (HP:0003587) | 2.08596281 |
79 | Syncope (HP:0001279) | 2.08443242 |
80 | Tetraplegia (HP:0002445) | 2.07720731 |
81 | Resting tremor (HP:0002322) | 2.05140015 |
82 | CNS hypomyelination (HP:0003429) | 2.04430080 |
83 | Peripheral hypomyelination (HP:0007182) | 2.00083503 |
84 | Pheochromocytoma (HP:0002666) | 1.97172327 |
85 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.95588974 |
86 | Specific learning disability (HP:0001328) | 1.94380431 |
87 | Type II lissencephaly (HP:0007260) | 1.94310461 |
88 | Abnormality of salivation (HP:0100755) | 1.93710553 |
89 | Congenital primary aphakia (HP:0007707) | 1.92736376 |
90 | Gait ataxia (HP:0002066) | 1.90737448 |
91 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.89731852 |
92 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.89731852 |
93 | Medial flaring of the eyebrow (HP:0010747) | 1.89567661 |
94 | Prolonged QT interval (HP:0001657) | 1.87074444 |
95 | Lower limb amyotrophy (HP:0007210) | 1.86802889 |
96 | Generalized hypopigmentation of hair (HP:0011358) | 1.86535782 |
97 | Bundle branch block (HP:0011710) | 1.85638380 |
98 | Ventricular fibrillation (HP:0001663) | 1.85251012 |
99 | Optic nerve hypoplasia (HP:0000609) | 1.85231200 |
100 | Thickened helices (HP:0000391) | 1.83714173 |
101 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.83555074 |
102 | Nephrogenic diabetes insipidus (HP:0009806) | 1.82280175 |
103 | Retinal dysplasia (HP:0007973) | 1.81812143 |
104 | Spastic tetraplegia (HP:0002510) | 1.79511572 |
105 | Choreoathetosis (HP:0001266) | 1.78592460 |
106 | Neuronal loss in central nervous system (HP:0002529) | 1.78376565 |
107 | Deeply set eye (HP:0000490) | 1.78265042 |
108 | Intention tremor (HP:0002080) | 1.78210918 |
109 | Hypoventilation (HP:0002791) | 1.77434270 |
110 | Abnormality of the periventricular white matter (HP:0002518) | 1.77351058 |
111 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.77345411 |
112 | Spastic tetraparesis (HP:0001285) | 1.77243681 |
113 | Lower limb muscle weakness (HP:0007340) | 1.76899854 |
114 | Rigidity (HP:0002063) | 1.76075616 |
115 | Unsteady gait (HP:0002317) | 1.75220247 |
116 | Apathy (HP:0000741) | 1.73286750 |
117 | Failure to thrive in infancy (HP:0001531) | 1.72956838 |
118 | Gastroesophageal reflux (HP:0002020) | 1.72113213 |
119 | Abnormality of saccadic eye movements (HP:0000570) | 1.71431782 |
120 | Widely spaced teeth (HP:0000687) | 1.71153277 |
121 | Abnormality of the corticospinal tract (HP:0002492) | 1.70051856 |
122 | Neuroendocrine neoplasm (HP:0100634) | 1.69947498 |
123 | Pointed chin (HP:0000307) | 1.69870288 |
124 | Abnormal EKG (HP:0003115) | 1.69839705 |
125 | Sleep apnea (HP:0010535) | 1.69679575 |
126 | Fair hair (HP:0002286) | 1.69677377 |
127 | Poor suck (HP:0002033) | 1.69535643 |
128 | Cerebral inclusion bodies (HP:0100314) | 1.69521495 |
129 | Limb dystonia (HP:0002451) | 1.68958994 |
130 | Autism (HP:0000717) | 1.66020853 |
131 | Delusions (HP:0000746) | 1.65128361 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 5.55222392 |
2 | NTRK3 | 4.84676418 |
3 | CASK | 3.70916776 |
4 | MAP3K4 | 3.15179908 |
5 | MAP3K9 | 3.02584888 |
6 | MAP2K7 | 2.95670923 |
7 | DAPK2 | 2.60251243 |
8 | MINK1 | 2.25951722 |
9 | DAPK1 | 2.16398742 |
10 | RIPK4 | 2.15483592 |
11 | TNIK | 2.11403995 |
12 | MAP3K12 | 2.08694480 |
13 | PRPF4B | 2.01762904 |
14 | MARK1 | 1.91947608 |
15 | FRK | 1.90511719 |
16 | PAK6 | 1.89746321 |
17 | PLK2 | 1.89335906 |
18 | KSR1 | 1.83910108 |
19 | BMPR1B | 1.83636406 |
20 | MAP2K4 | 1.79411614 |
21 | NTRK2 | 1.68108676 |
22 | KSR2 | 1.66863172 |
23 | CDK19 | 1.65803506 |
24 | CAMKK1 | 1.54077133 |
25 | SIK3 | 1.47879659 |
26 | CDK5 | 1.44917986 |
27 | FES | 1.43387153 |
28 | PRKD3 | 1.32050305 |
29 | AKT3 | 1.31952702 |
30 | PRKCG | 1.30712099 |
31 | MAP3K13 | 1.26427209 |
32 | ARAF | 1.26118567 |
33 | CCNB1 | 1.23754392 |
34 | MAPK13 | 1.22137923 |
35 | GRK5 | 1.16923913 |
36 | BMPR2 | 1.16923220 |
37 | SIK2 | 1.16351856 |
38 | CAMK2A | 1.14607209 |
39 | NTRK1 | 1.13538230 |
40 | CAMKK2 | 1.13086956 |
41 | SGK2 | 1.11103231 |
42 | SGK494 | 1.08334477 |
43 | SGK223 | 1.08334477 |
44 | STK38 | 1.05714199 |
45 | CAMK2B | 1.05386239 |
46 | PTK2B | 1.04594746 |
47 | OXSR1 | 0.98517174 |
48 | MAPK12 | 0.97756172 |
49 | CAMK1 | 0.97056607 |
50 | CDK18 | 0.89370209 |
51 | RAF1 | 0.87961380 |
52 | PKN1 | 0.87549050 |
53 | NME1 | 0.85094741 |
54 | CDK15 | 0.81056292 |
55 | FGFR2 | 0.80608595 |
56 | SGK1 | 0.78180676 |
57 | PNCK | 0.77402986 |
58 | SGK3 | 0.77279705 |
59 | CDK14 | 0.76089372 |
60 | MAP3K2 | 0.74769442 |
61 | TAOK1 | 0.74243494 |
62 | BRAF | 0.70558142 |
63 | MARK2 | 0.70323733 |
64 | WNK4 | 0.70154013 |
65 | CDK11A | 0.69857534 |
66 | BCR | 0.69565601 |
67 | MAP3K6 | 0.69236755 |
68 | UHMK1 | 0.68520140 |
69 | DYRK1A | 0.66991782 |
70 | STK11 | 0.64660084 |
71 | PRKCE | 0.64597420 |
72 | PRKCH | 0.60652671 |
73 | TSSK6 | 0.60056048 |
74 | CSNK1G3 | 0.59925774 |
75 | DYRK2 | 0.59019110 |
76 | TGFBR1 | 0.58066898 |
77 | ACVR1B | 0.57781043 |
78 | TYRO3 | 0.56714000 |
79 | CSNK1A1L | 0.56701168 |
80 | PDK1 | 0.54861219 |
81 | WNK1 | 0.54115492 |
82 | CAMK2D | 0.53781614 |
83 | CSNK1G2 | 0.52561722 |
84 | NEK6 | 0.52394966 |
85 | PRKCI | 0.51358797 |
86 | PINK1 | 0.50782875 |
87 | TNK2 | 0.50546043 |
88 | PDPK1 | 0.50114668 |
89 | FER | 0.50010582 |
90 | FGR | 0.49621778 |
91 | CAMK4 | 0.47833679 |
92 | MAP2K1 | 0.47593755 |
93 | INSRR | 0.47157944 |
94 | CAMK2G | 0.46879727 |
95 | ALK | 0.46387260 |
96 | DAPK3 | 0.45848114 |
97 | RET | 0.45233440 |
98 | PAK3 | 0.43384157 |
99 | WNK3 | 0.42375327 |
100 | * RPS6KA3 | 0.42194563 |
101 | KIT | 0.42144968 |
102 | CSNK1D | 0.40310518 |
103 | MAP3K1 | 0.38913347 |
104 | GRK1 | 0.38360216 |
105 | PRKCZ | 0.37619314 |
106 | MAP4K2 | 0.37538850 |
107 | CSNK1G1 | 0.37247410 |
108 | * PRKG1 | 0.35835194 |
109 | SYK | 0.35505920 |
110 | FYN | 0.35395205 |
111 | CDK3 | 0.34862391 |
112 | MAP3K7 | 0.33641277 |
113 | MAPK10 | 0.33098849 |
114 | MAP3K11 | 0.31642770 |
115 | PRKACA | 0.31156699 |
116 | DMPK | 0.31045737 |
117 | LATS2 | 0.30782387 |
118 | CAMK1G | 0.30534630 |
119 | PHKG2 | 0.30181747 |
120 | PHKG1 | 0.30181747 |
121 | * PRKCB | 0.29804903 |
122 | PRKCA | 0.29779792 |
123 | MAPK7 | 0.29357563 |
124 | * CSNK1E | 0.28437281 |
125 | CDC42BPA | 0.28015988 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.28272712 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.58399594 |
3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.98786270 |
4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.96061335 |
5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.86663621 |
6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.86621392 |
7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.83315220 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.79849060 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.74742084 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.72354037 |
11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.27397916 |
12 | Salivary secretion_Homo sapiens_hsa04970 | 2.22743541 |
13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.21317391 |
14 | Insulin secretion_Homo sapiens_hsa04911 | 1.94315012 |
15 | Taste transduction_Homo sapiens_hsa04742 | 1.90623335 |
16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89625402 |
17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.82632592 |
18 | Long-term depression_Homo sapiens_hsa04730 | 1.81047228 |
19 | Renin secretion_Homo sapiens_hsa04924 | 1.81033645 |
20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.79680384 |
21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78981733 |
22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.77643683 |
23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.73062601 |
24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.71202281 |
25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.69162800 |
26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.48172717 |
27 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.35044147 |
28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.32228055 |
29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.31413671 |
30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29689984 |
31 | Gap junction_Homo sapiens_hsa04540 | 1.26219366 |
32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22665963 |
33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17727011 |
34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14093890 |
35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13493977 |
36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10128327 |
37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.09560288 |
38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08401067 |
39 | Axon guidance_Homo sapiens_hsa04360 | 1.05374203 |
40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04677971 |
41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97317424 |
42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97048537 |
43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96757082 |
44 | Glioma_Homo sapiens_hsa05214 | 0.96321862 |
45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96290476 |
46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96115883 |
47 | Melanogenesis_Homo sapiens_hsa04916 | 0.88477156 |
48 | Phototransduction_Homo sapiens_hsa04744 | 0.88080536 |
49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87885218 |
50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83341127 |
51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82077863 |
52 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.75026912 |
53 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.74695278 |
54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74533288 |
55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72873993 |
56 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66802386 |
57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66766188 |
58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66487424 |
59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65380313 |
60 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61773207 |
61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61490957 |
62 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58758747 |
63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56158113 |
64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55527321 |
65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54175576 |
66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53507908 |
67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53247154 |
68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51886177 |
69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51063352 |
70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49962874 |
71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49208064 |
72 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48935583 |
73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48843070 |
74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47409049 |
75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47360737 |
76 | Alcoholism_Homo sapiens_hsa05034 | 0.45643998 |
77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45432113 |
78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45221434 |
79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43450933 |
80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41871012 |
81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40145101 |
82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39895043 |
83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38490289 |
84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37360278 |
85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37152704 |
86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36085275 |
87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34890217 |
88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34462330 |
89 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33394142 |
90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31993824 |
91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31838194 |
92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.30915117 |
93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30497636 |
94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30065037 |
95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29604867 |
96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28305984 |
97 | Endocytosis_Homo sapiens_hsa04144 | 0.28190499 |
98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28155662 |
99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27074678 |
100 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26092680 |
101 | Tight junction_Homo sapiens_hsa04530 | 0.25393734 |
102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24711481 |
103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24387460 |
104 | Phagosome_Homo sapiens_hsa04145 | 0.23948323 |
105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23447157 |
106 | Mineral absorption_Homo sapiens_hsa04978 | 0.22794214 |
107 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.22534611 |
108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22053023 |
109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21963221 |
110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21219692 |
111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.20966438 |
112 | Bile secretion_Homo sapiens_hsa04976 | 0.20830010 |
113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20256980 |
114 | Prion diseases_Homo sapiens_hsa05020 | 0.19952960 |
115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.18626849 |
116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.17853216 |
117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.17687536 |